In vitro effects of neuropeptide Y in rat neocortical and hippocampal tissue

Neuroscience Letters

Volumn 492, Issue 1, 2011, Pages 43-46

  Kovac, Stjepana ^a,b   Megalogeni, Maria ^a   Walker, Matthew ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Hippocampus; Neocortex; Neocortical epilepsy; Neuropeptide Y

Indexed keywords

NEUROPEPTIDE Y;

ANIMAL TISSUE; ARTICLE; EPILEPTIC DISCHARGE; EPILEPTOGENESIS; HIPPOCAMPUS; MALE; NEOCORTEX; NONHUMAN; PRIORITY JOURNAL; RAT;

ACTION POTENTIALS; ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; EPILEPSY; HIPPOCAMPUS; MALE; NEOCORTEX; NEUROPEPTIDE Y; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79952008476     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.01.050     Document Type: Article

References (29)

1. Baraban S.C. Neuropeptide Y and epilepsy: recent progress, prospects and controversies. Neuropeptides 2004, 38(4):261-265.
2. Bijak M Neuropeptide Y suppresses epileptiform activity in rat frontal cortex and hippocampus in vitro via different NPY receptor subtypes. Neurosci. Lett. 1999, 268(3):115-118.
3. Bijak M. Neuropeptide Y reduces epileptiform discharges and excitatory synaptic transmission in rat frontal cortex in vitro. Neuroscience 2000, 96(3):487-494.
4. Colmers W.F., Klapstein G.J., Fournier A., St-Pierre S., Treherne K.A. Presynaptic inhibition by neuropeptide Y in rat hippocampal slice in vitro is mediated by a Y2 receptor. Br. J. Pharmacol. 1991, 102(1):41-44.
5. Colmers W.F., Lukowiak K., Pittman Q.J. Neuropeptide Y reduces orthodromically evoked population spike in rat hippocampal CA1 by a possibly presynaptic mechanism. Brain Res. 1985, 346(2):404-408.
6. Colmers W.F., Lukowiak K., Pittman Q.J. Presynaptic action of neuropeptide Y in area CA1 of the rat hippocampal slice. J. Physiol. 1987, 383:285-299.
7. Creager R., Dunwiddie T., Lynch G. Paired-pulse and frequency facilitation in the CA1 region of the in vitro rat hippocampus. J. Physiol. 1980, 299:409-424.
8. Dreier J.P., Heinemann U. Late low magnesium-induced epileptiform activity in rat entorhinal cortex slices becomes insensitive to the anticonvulsant valproic acid. Neurosci. Lett. 1990, 119(1):68-70.
9. El Bahh B., Balosso S., Hamilton T., Herzog H., Beck-Sickinger A.G., Sperk G., Gehlert D.R., Vezzani A., Colmers W.F. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y2 and not Y1 receptors. Eur. J. Neurosci. 2005, 22(6):1417-1430.
10. Foti S., Haberman R.P., Samulski R.J., McCown T.J. Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo. Gene Ther. 2007, 14(21):1534-1536.
11. Jeha L.E., Najm I., Bingaman W., Dinner D., Widdess-Walsh P., Luders H. Surgical outcome and prognostic factors of frontal lobe epilepsy surgery. Brain 2007, 130(Pt 2):574-584.
12. Klapstein G.J., Colmers W.F. 4-Aminopyridine and low Ca2+ differentiate presynaptic inhibition mediated by neuropeptide Y, baclofen and 2-chloroadenosine in rat hippocampal CA1 in vitro. Br. J. Pharmacol. 1992, 105(2):470-474.
13. Klapstein G.J, Colmers W.F. On the sites of presynaptic inhibition by neuropeptide Y in rat hippocampus in vitro. Hippocampus 1993, 3(1):103-111.
14. Klapstein G.J., Colmers W.F., Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro. J. Neurophysiol. 1997, 78(3):1651-1661.
15. Kofler N., Kirchmair E., Schwarzer C., Sperk G. Altered expression of NPY-Y1 receptors in kainic acid induced epilepsy in rats. Neurosci. Lett. 1997, 230(2):129-132.
16. Kopp J., Xu Z.Q., Zhang X., Pedrazzini T., Herzog H., Kresse A., Wong H., Walsh J.H., Hokfelt T. Expression of the neuropeptide Y Y1 receptor in the CNS of rat and of wild-type and Y1 receptor knock-out mice. Focus on immunohistochemical localization. Neuroscience 2002, 111(3):443-532.
17. Manford M., Hart Y.M., Sander J.W., Shorvon S.D. National General Practice Study of Epilepsy (NGPSE): partial seizure patterns in a general population. Neurology 1992, 42(10):1911-1917.
18. Noe F., Vaghi V., Balducci C., Fitzsimons H., Bland R., Zardoni D., Sperk G., Carli M., During M.J., Vezzani A. Anticonvulsant effects and behavioural outcomes of rAAV serotype 1 vector-mediated neuropeptide Y overexpression in rat hippocampus. Gene Ther. 2010, 17(5):643-652.
19. Richichi C., Lin E.J., Stefanin D., Colella D., Ravizza T., Grignaschi G., Veglianese P., Sperk G., During M.J., Vezzani A. Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus. J. Neurosci. 2004, 24(12):3051-3059.
20. Schwarzer C., Kofler N., Sperk G. Up-regulation of neuropeptide Y-Y2 receptors in an animal model of temporal lobe epilepsy. Mol. Pharmacol. 1998, 53(1):6-13.
21. Schwarzer C., Williamson J.M., Lothman E.W., Vezzani A., Sperk G. Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy. Neuroscience 1995, 69(3):831-845.
22. Sperk G, Marksteiner J., Gruber B., Bellmann R., Mahata M., Ortler M. Functional changes in neuropeptide Y- and somatostatin-containing neurons induced by limbic seizures in the rat. Neuroscience 1992, 50(4):831-846.
23. Vezzani A., Schwarzer C., Lothman E.W., Williamson J., Sperk G. Functional changes in somatostatin and neuropeptide Y containing neurons in the rat hippocampus in chronic models of limbic seizures. Epilepsy Res. 1996, 26(1):267-279.
24. Vezzani A., Sperk G., Colmers W.F. Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci. 1999, 22(1):25-30.
25. Vezzani A., Moneta D., Mule F., Ravizza T., Gobbi M., French-Mullen J. Plastic changes in neuropeptide Y receptor subtypes in experimental models of limbic seizures. Epilepsia 2000, 41:115-121.
26. Wahlestedt C., Yanaihara N., Hakanson R. Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides. Regul. Pept. 1986, 13(3-4):307-318.
27. Widdowson P.S., Buckingham R., Williams G. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors. Brain Res. 1997, 778(1):242-250.
28. Woldbye D.P., Madsen T.M., Larsen P.J., Mikkelsen J.D., Bolwig T.G., Neuropeptide Y inhibits hippocampal seizures and wet dog shakes. Brain Res. 1996, 737(1-2):162-168.
29. Woldbye D.P., Nanobashvili A., Husum H., Bolwig T.G., Kokaia M., Neuropeptide Y inhibits in vitro epileptiform activity in the entorhinal cortex of mice. Neurosci. Lett. 2002, 333(2):127-130.